Researchers at Israel’s Technion Institute have identified the specific part of a protein within a T-cell that tells it to attack a virus or pathogen. The discovery of this “regulatory trigger” may lead to medications to prevent cytokine storms in coronavirus patients or to cure autoimmune diseases.
Dialing down the immune response
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.